Reaction
Eyelid Skin Dryness reporting signals
As of the last recalculation, Eyelid Skin Dryness appears in 1,154 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is DUPILUMAB (PRR 53.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dupilumab | 643 | 53.1 | 53.2 |
| Dorzolamide Hydrochloride And Timolol Maleate | 19 | 44.1 | 44.2 |
| Bimatoprost | 63 | 41.6 | 41.7 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 16 | 12.5 | 12.5 |
| Clobetasol Propionate Ointment Usp, 0.05% | 7 | 12.3 | 12.3 |
| Clobetasol Propionate | 7 | 12.3 | 12.3 |
| Lifitegrast | 11 | 12.3 | 12.3 |
| Carboxymethylcellulose Sodium | 6 | 11.6 | 11.6 |
| Adapalene | 89 | 9.5 | 9.5 |
| Triamcinolone Acetonide | 16 | 9.5 | 9.5 |
| Brimonidine Tartrate | 9 | 9.2 | 9.2 |
| Sulfur | 4 | 8.6 | 8.6 |
| Salicylic Acid | 23 | 8.0 | 8.0 |
| Cenegermin-Bkbj | 4 | 6.0 | 6.0 |
| Crisaborole | 3 | 5.7 | 5.7 |